Analyst Ratings for MEI Pharma (MEIP)

MEIP Rating Summary

MEIP Price Target Summary

* Over Last 12-Mos
  |   Expand Research on MEIP
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $4.50 (+818.4%) * Over Last 12-Mos
Rating Score: 5.7 / 10   Percentile Rank: 57%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
3/25/2022 Wells Fargo N/A Downgrade Equal Weight
(Overweight)
2.00
(13.00)
1.80
(0.49)
-72.78% Details
3/25/2022 Jefferies Chris Howerton Downgrade Hold
(Buy)
1.00
(4.00)
1.80
(0.49)
-72.78% Details